Follow-up after conversion to Neoral in stable heart transplant recipients.
Pethig
K
K
Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany.
Geiger
M
M
Korn
A
A
Grote
M
M
Christians
U
U
Wahlers
T
T
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine